Mala Sachdeva

Happy International Women’s Day!

Save the Date | 2026 Women in Nephrology Leadership Conference 📍 The Yale Club, New York City 📅 September 25–26, 2026 Two days dedicated to leadership, growth, and connection across nephrology. More details to follow.

We’re proud to announce our newly elected WIN Councilors Dr. Shreepriya Mangalgi Dr. Manisha Jhamb Dr. Amanda Leonberg-Yoo Thank you for stepping forward to serve and strengthen our community. @dr_shreepriya @ManishaJhambMD @AmandaLeonberg

Congratulations to Dr. @Reem_A_Mustafa, elected as President-Elect of Women in Nephrology. We look forward to her leadership and vision in the year ahead.

Happy National Women Physicians Day! 👩🏻‍⚕️🩺

We are pleased to share the publication of the KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD), a comprehensive update to the 2012 guideline. Read the guideline in @Kidney_Int: kdigo.co/KDIGO-Anemia-i… Visit the KDIGO Anemia in CKD Guideline website to download the guideline, executive summary, and news release: kdigo.org/guidelines/ane… Co-chaired by Dr. Jodie Babitt (US) and Dr. Marcello Tonelli (CA), the guideline provides evidence-based recommendations for diagnosing and managing anemia across the CKD continuum, including dialysis and kidney transplantation. “This guideline represents a major step forward in how we approach anemia in CKD,” said Dr. Babitt. “It emphasizes a systematic evaluation of anemia and iron deficiency, clearer guidance on when and how to use oral and intravenous iron, and integrates new evidence on emerging therapies while reinforcing the need to avoid overtreatment and to prioritize safety and shared decision-making.” “This guideline reflects a decade of new evidence and the increasing complexity of anemia management in people with chronic kidney disease,” said Dr. Tonelli. “We evaluated a large body of randomized trial data across iron therapies, ESAs, HIF-PHIs, and transfusion strategies, with careful attention to both benefits and harms, to support consistent, evidence-informed anemia care across diverse healthcare systems, resource settings, and patient populations worldwide.” #anemia #CKD

Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) linkinghub.elsevier.com/retrieve/pii/S… @StevenFishbane @Kidney_Int @ISNkidneycare

The WIN 2025 Election is underway form Jan 1-Jan 31, 2026. Members, cast your ballot for President-Elect & Councilors-at-Large here ➡️womeninnephrology.org/2025-win-elect… Having issues with the portal? Email win@womeninnephrology.org

Great group of incoming fellows!!

Original Article: Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias (POTCAST trial) nej.md/4oQtHTN Editorial: Targeting Potassium for Prevention of Ventricular Arrhythmias nej.md/49smjc2 #Cardiology

Honored to contribute at ASN 25 @ASNKidney and to moderate, with Prof. Vivekanand Jha, the session: “Hypertension Treatment in Special Groups: Dialysis, Transplant, Frail Older Adults & Pregnancy.” A key highlight was the Sharon Silbiger, MD, Endowed Lectureship especially meaningful for all women in nephrology presented by @womeninnephro President @mala_sachdeva Always grateful for the chance to reconnect with friends and colleagues from around the world. #KidneyWK @ISNkidneycare @ERAkidney @ifkf_wka

Congrats Hitesh! @HofstraKidney

#AHA25 In >17,000 women from the All of Us Research Program, hypertensive disorders of pregnancy were independently associated with nearly 2-fold higher risk of premature CVD, regardless of pre-pre... ahajrnls.org/3LsjMVo @ErinMichos @AllisonGHaysMD @ASWallaceEpi @DrAnumMinhas

WIN BOOTH 1132 at ASN Visit us!!

WIN BOOTH 1132 at ASN Visit us!!

Had to stop by the @womeninnephro (WIN) table and take a photo with these wonderful female Nephrologists! #proudwinmember @dr_shreepriya #reemamustafa #stephanierodriguez @ASNKidney #kidneyweek @mala_sachdeva @jiahweing

Antihypertensive treatment adherence during pregnancy by race and ethnicity - AHT utilization and >80% PDC during the second half of pregnancy among initiators ow.ly/XNw950XoOWK

AJOG Presents: Antihypertensive treatment adherence during pregnancy by race and ethnicity ow.ly/XNw950XoOWK

WIN’s Nancy Gary Lecture 2025 at ASN!

WIN networking reception